Biocomposites

At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue. With over 25 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.

With a singular focus on developing innovative calcium compound medical devices, Biocomposites has gained a deep expertise in musculoskeletal infections, trauma, spine and sports injuries. Connected with universities and hospitals around the world, Biocomposites continues to innovate in infection management to support surgeons and their patients.

Possessing unique characteristics for regenerating bone and managing dead space, our products are opening new possibilities for surgeons around the world in trauma, spine, sports injuries and musculoskeletal infections – one of the biggest healthcare challenges of the 21st century.

Company Growth (employees)
Type
Private
HQ
Keele, GB
Size (employees)
83 (est)+21%
Biocomposites is headquartered in Keele, GB

Biocomposites Office Locations

Biocomposites has an office in Keele
Keele, GB (HQ)
Science Park University Of Keele

Biocomposites Data and Metrics

Summary Metrics

Time since last funding

about 1 month

Biocomposites Financial Metrics

Biocomposites's revenue was reported to be £15.7 m in FY, 2015 which is a 52% increase from the previous period.
GBP

Revenue (FY, 2015)

15.7 m

Revenue growth (FY, 2014 - FY, 2015), %

52%

Net income (FY, 2015)

7.3 m

Cash (31-Dec-2015)

8.6 m
GBPFY, 2013FY, 2014FY, 2015

Revenue

9 m10.3 m15.7 m

Revenue growth, %

15%52%

Pre tax profit

2.9 m2.7 m7.9 m

Net Income

2.2 m2.5 m7.3 m
GBPFY, 2013FY, 2014FY, 2015

Cash

3.1 m4.5 m8.6 m

Accounts Receivable

373 k448 k660 k

Current Assets

6.5 m8.5 m14.8 m

PP&E

740 k659 k656 k

Total Assets

7.2 m9.2 m15.4 m

Accounts Payable

583 k166 k615 k

Current Liabilities

2 m1.6 m2.4 m

Total Liabilities

4 m3.4 m2.5 m

Retained Earnings

2.2 m2.5 m7.3 m

Total Equity

3.2 m5.8 m13 m

Financial Leverage

2.2 x1.6 x1.2 x
GBPFY, 2013FY, 2014FY, 2015

Income Taxes Paid

(728 k)(169 k)(585 k)
Y, 2015

Financial Leverage

1.2 x

Biocomposites Company Life and Culture

You may also be interested in